Evidence map›Paper›PMID 27388619›Full record

ArticlePloS one2016

Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study.

Walid Albanna, Catharina Conzen, Miriam Weiss, Hans Clusmann, Matthias Fuest, Marguerite Mueller, Marc Alexander Brockmann, Walthard Vilser, Arno Schmidt-Trucksäss, Anke Hoellig and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Walid AlbannaDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Catharina ConzenDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Miriam WeissDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Hans ClusmannDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Matthias FuestDepartment of Ophthalmology, RWTH Aachen University, Aachen, Germany.
Marguerite MuellerDepartment of Diagnostic and Interventional Neuroradiology, RWTH Aachen University, Aachen, Germany.
Marc Alexander BrockmannDepartment of Diagnostic and Interventional Neuroradiology, RWTH Aachen University, Aachen, Germany.
Walthard VilserIMEDOS Systems UG, Jena, Germany.
Arno Schmidt-TrucksässDepartment of Exercise and Health Sciences, University of Basel, Basel, Switzerland.
Anke HoelligDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Marcel SeizDepartment of Neurosurgery, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany.
Claudius ThoméDepartment of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.
Konstantin KotliarDepartment of Medical Engineering and Technomathematics, FH Aachen University of Applied Sciences, Aachen, Germany.
Gerrit Alexander SchubertDepartment of Neurosurgery, RWTH Aachen University, Aachen, Germany.
RWTH Aachen University · DEFH Aachen · DEHeidelberg University · DEInnsbruck Medical University · ATUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTimely detection of impending delayed cerebral ischemia after subarachnoid hemorrhage (SAH) is essential to improve outcome, but poses a diagnostic challenge. Retinal vessels as an embryological part of the intracranial vasculature are easily accessible for analysis and may hold the key to a new and non-invasive monitoring technique. This investigation aims to determine the feasibility of standardized retinal vessel analysis (RVA) in the context of SAH.

methodsIn a prospective pilot study, we performed RVA in six patients awake and cooperative with SAH in the acute phase (day 2-14) and eight patients at the time of follow-up (mean 4.6±1.7months after SAH), and included 33 age-matched healthy controls. Data was acquired using a manoeuvrable Dynamic Vessel Analyzer (Imedos Systems UG, Jena) for examination of retinal vessel dimension and neurovascular coupling.

resultsImage quality was satisfactory in the majority of cases (93.3%). In the acute phase after SAH, retinal arteries were significantly dilated when compared to the control group (124.2±4.3MU vs 110.9±11.4MU, p<0.01), a difference that persisted to a lesser extent in the later stage of the disease (122.7±17.2MU, p<0.05). Testing for neurovascular coupling showed a trend towards impaired primary vasodilation and secondary vasoconstriction (p = 0.08, p = 0.09 resp.) initially and partial recovery at the time of follow-up, indicating a relative improvement in a time-dependent fashion.

conclusionRVA is technically feasible in patients with SAH and can detect fluctuations in vessel diameter and autoregulation even in less severely affected patients. Preliminary data suggests potential for RVA as a new and non-invasive tool for advanced SAH monitoring, but clinical relevance and prognostic value will have to be determined in a larger cohort.

Indexed as

AdultAgedAneurysmBrain IschemiaCase-Control StudiesCerebrovascular CirculationFemaleHumansMaleMiddle AgedMonitoring, PhysiologicNimodipinePilot ProjectsProspective StudiesRetinal VesselsSubarachnoid HemorrhageNimodipine

Identifiers

PMID27388619
PMCPMC4936715
OpenAlexW2461100304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.